StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
486
This month
39
This week
4
This year
197
Yesterday
4
Publishing Date
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 22
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 18
3
2022 - 05 - 17
3
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 04 - 25
3
2022 - 04 - 06
3
2022 - 03 - 31
3
2022 - 03 - 30
3
2022 - 03 - 25
6
2022 - 03 - 23
3
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 16
3
2022 - 03 - 14
3
2022 - 03 - 08
4
2022 - 03 - 04
4
2022 - 03 - 01
4
2022 - 02 - 28
3
2021 - 12 - 22
6
2021 - 12 - 20
4
2021 - 12 - 16
3
2021 - 12 - 14
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
2021 - 09 - 08
3
2021 - 08 - 31
4
2021 - 08 - 25
4
2021 - 08 - 24
3
2021 - 08 - 19
5
2021 - 08 - 06
3
2021 - 08 - 05
6
2021 - 08 - 03
3
2021 - 07 - 16
3
2021 - 07 - 08
3
2021 - 06 - 25
3
2021 - 06 - 04
3
2021 - 06 - 02
4
2021 - 05 - 10
4
2021 - 05 - 07
3
2021 - 04 - 28
3
2021 - 04 - 13
4
2021 - 04 - 09
3
2021 - 04 - 07
3
2021 - 03 - 30
3
2021 - 03 - 18
5
2021 - 03 - 16
3
Sector
Commercial services
5
Communications
1
Consumer durables
3
Consumer non-durables
1
Distribution services
1
Electronic technology
4
Energy minerals
3
Finance
1
Finance and insurance
3
Health services
9
Health technology
486
Manufacturing
93
N/a
4
Process industries
5
Producer manufacturing
8
Professional, scientific, and technical services
4
Retail trade
1
Technology services
7
Tags
Als
6
America
11
Antibody
8
Application
8
Approval
14
Biocanada
6
Biosimilar
13
Breast cancer
9
Cancer
35
Car-t
7
Covid
17
Covid-19
8
Device
14
Diabetes
9
Diabetic
6
Diagnostic
7
Disease
35
Drug
73
Drug delivery
11
Earnings
10
Ema
6
Europe
11
Eye
10
Fda
16
Fda approval
8
Financial results
13
For
20
Gene therapies
8
Gene therapy
11
Growing
10
Growth
84
Health
6
Immunotherapy
8
Injection
7
Iot
7
Leukemia
9
Liver
17
Macular
6
Market
79
Molecular
6
Myeloid leukemia
6
N/a
409
Novartis
46
Order
6
Patent
8
People
13
Pharm-country
6
Pharma
8
Positive
11
Potential
7
Report
39
Research
40
Respiratory
6
Results
26
T-cell
7
Therapeutics
22
Therapy
47
Treatment
56
Trial
12
Vaccine
9
Entities
3m company
8
Abbott laboratories
37
Abbvie inc.
66
Adaptimmune therapeutics plc
5
Agilent technologies, inc.
3
Alkermes plc
5
Amgen inc.
63
Arrival
4
Astellas pharma inc
22
Astrazeneca plc
75
Bausch health companies inc.
31
Baxter international inc.
13
Becton, dickinson and company
11
Beigene, ltd.
6
Biogen inc.
16
Bluebird bio, inc.
9
Boston scientific corporation
12
Bristol-myers squibb company
46
Cellectis s.a.
3
Cryolife, inc.
3
Cti biopharma corp.
3
Dx group
3
Eli lilly and company
44
Endo international plc
4
General electric company
3
Genmab a/s
13
Gilead sciences, inc.
6
Glaxosmithkline plc
111
Immutep limited
3
Incyte corporation
13
Insulet corporation
3
Integra lifesciences holdings corporation
6
Ionis pharmaceuticals, inc.
3
Jazz pharmaceuticals plc
5
Johnson & johnson
105
Koninklijke philips n.v.
6
Mallinckrodt plc
3
Medtronic plc
21
Moderna, inc.
3
Morphosys ag
6
Mylan n.v.
21
Neurocrine biosciences, inc.
3
Nic inc.
3
Nikon corp
3
Novartis ag
486
Novo nordisk a/s
6
Perrigo company
3
Pfizer, inc.
36
Qiagen n.v.
4
Regenxbio inc.
5
Sanofi
107
Smith & nephew plc
5
Stryker corporation
8
Takeda pharmaceutical company limited
20
Teva pharmaceutical industries ltd
50
Thermo fisher scientific inc
16
Uniqure n.v.
9
Vericel corporation
6
Viatris inc.
24
Xencor, inc.
5
Symbols
AAPL
481
ABB
606
ABBV
480
ABLZF
347
ABT
682
AMGN
342
APO
270
ARVL
1727
AZN
298
BDX
400
BMY
354
BNPQF
544
BNPQY
544
BNPZY
543
BSX
293
CNY
434
CSCO
428
DHR
339
DOW
287
ERIC
721
EXTR
320
F
267
FNCTF
2047
FRBA
314
GE
454
GOOG
324
GOOGL
327
GSK
406
HON
727
HUBS
997
IBM
330
INR
437
INTC
408
JNJ
2194
LLY
862
LYV
309
MDT
588
MLPY
435
MMM
448
MS
2098
MSFT
596
NOK
280
NVO
295
NVS
486
NVSEF
284
OCX
269
ORCL
552
PFE
372
PHG
457
PPRUF
376
PPRUY
377
SAP
662
SAPGF
397
SNOW
337
SNY
1873
SNYNF
923
TMO
629
TOT
718
URR
433
VZ
444
Exchanges
Amex
3
Lse
56
Nasdaq
409
Nyse
486
Tsx
13
Crawled Date
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 22
3
2022 - 06 - 17
6
2022 - 06 - 06
3
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 18
3
2022 - 05 - 17
3
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 04 - 25
3
2022 - 04 - 06
3
2022 - 03 - 31
3
2022 - 03 - 30
3
2022 - 03 - 25
6
2022 - 03 - 23
3
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 16
3
2022 - 03 - 14
4
2022 - 03 - 08
4
2022 - 03 - 04
4
2022 - 03 - 01
3
2022 - 02 - 28
3
2021 - 12 - 22
5
2021 - 12 - 20
4
2021 - 12 - 16
3
2021 - 12 - 14
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
2021 - 09 - 08
3
2021 - 09 - 01
4
2021 - 08 - 25
4
2021 - 08 - 24
3
2021 - 08 - 19
5
2021 - 08 - 06
3
2021 - 08 - 05
6
2021 - 08 - 03
3
2021 - 07 - 16
3
2021 - 07 - 08
3
2021 - 06 - 25
3
2021 - 06 - 04
3
2021 - 06 - 02
4
2021 - 05 - 10
4
2021 - 05 - 07
3
2021 - 04 - 28
3
2021 - 04 - 13
4
2021 - 04 - 09
3
2021 - 04 - 07
3
2021 - 03 - 30
3
2021 - 03 - 18
5
2021 - 03 - 04
2
Crawled Time
00:00
6
00:20
3
01:00
11
01:08
1
02:00
4
03:00
9
04:00
7
04:20
2
05:00
4
06:00
20
06:03
2
07:00
17
08:00
15
08:23
1
09:00
13
10:00
11
11:00
19
12:00
39
12:15
6
12:20
8
12:30
9
13:00
14
13:14
1
13:15
7
13:20
3
13:30
5
13:35
1
13:58
1
14:00
32
14:15
2
14:20
2
14:30
2
15:00
25
15:15
4
15:20
3
15:30
5
16:00
25
16:01
1
16:20
2
17:00
35
18:00
21
19:00
14
20:00
20
20:20
1
21:00
18
22:00
22
22:01
1
23:00
11
23:09
1
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
1
spacfeed.com
1
www.biospace.com
77
www.globenewswire.com
101
www.prnewswire.com
304
www.voyagertherapeutics.com
1
Sort by:
after hours percent change
|
delayed percent change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVS
save search
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published:
2022-06-27
(Crawled : 16:00)
- prnewswire.com
AZNCF
|
$127.2501
|
|
Health Technology
|
1.93%
|
O:
-1.55%
H:
4.43%
C:
0.03%
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
0.77%
|
O:
1.86%
H:
1.05%
C:
0.24%
LLY
|
News
S
|
$317.62
-2.95%
-0.03%
|
|
Health Technology
|
-0.55%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
$43.35
-0.8%
0.19%
|
|
Health Technology
|
-0.78%
|
O:
-0.16%
H:
0.61%
C:
0.18%
GLAXF
|
$21.99
|
|
Health Technology
|
4.22%
|
O:
0.47%
H:
3.73%
C:
3.73%
PFE
|
News
|
$50.66
-2.35%
0.4%
|
|
Health Technology
|
-0.16%
|
O:
1.46%
H:
1.45%
C:
0.78%
SPPI
A
|
$0.8436
-1.91%
1.74%
|
|
Health Technology
|
-3.43%
|
O:
0.0%
H:
2.28%
C:
-2.27%
SNYNF
|
News
|
$108.84
|
|
Health Technology
|
4.15%
|
O:
4.15%
H:
0.0%
C:
0.0%
BMY
|
$78.7
-1.6%
0.38%
|
|
Health Technology
|
0.1%
|
O:
0.78%
H:
1.72%
C:
0.95%
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
-0.55%
|
O:
0.53%
H:
0.0%
C:
0.0%
AZN
|
$65.94
-0.86%
0.21%
|
|
Health Technology
|
-0.86%
|
O:
-0.36%
H:
1.22%
C:
0.38%
immunotherapy
report
therapy
cancer
market
Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published:
2022-06-27
(Crawled : 15:20)
- prnewswire.com
CRNX
|
$17.74
-4.57%
0.0%
|
|
Health Technology
|
-9.54%
|
O:
0.66%
H:
1.22%
C:
-5.83%
AZN
|
$65.94
-0.86%
0.21%
|
|
Health Technology
|
-0.86%
|
O:
-0.36%
H:
1.22%
C:
0.38%
ADAP
S
|
$1.74
2.35%
5.88%
|
|
Health Technology
|
7.41%
|
O:
1.85%
H:
6.67%
C:
3.03%
AZNCF
|
$127.2501
|
|
Health Technology
|
1.93%
|
O:
-1.55%
H:
4.43%
C:
0.03%
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
0.77%
|
O:
1.86%
H:
1.05%
C:
0.24%
GSK
|
$43.35
-0.8%
0.19%
|
|
Health Technology
|
-0.78%
|
O:
-0.16%
H:
0.61%
C:
0.18%
GLAXF
|
$21.99
|
|
Health Technology
|
4.22%
|
O:
0.47%
H:
3.73%
C:
3.73%
AMGN
|
$243.6
-0.51%
0.47%
|
|
Health Technology
|
-0.76%
|
O:
-0.08%
H:
0.45%
C:
-0.13%
treatment
therapy
cancer
market
Valued to be $104.2 Million by 2026, Eye Health Supplements Slated for Robust Growth Worldwide
Published:
2022-06-27
(Crawled : 14:00)
- prnewswire.com
PFE
|
News
|
$50.66
-2.35%
0.4%
|
|
Health Technology
|
-0.16%
|
O:
1.46%
H:
1.45%
C:
0.78%
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
0.77%
|
O:
1.86%
H:
1.05%
C:
0.24%
for
health
eye
growth
Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published:
2022-06-27
(Crawled : 12:20)
- prnewswire.com
JNJ
|
News
|
$176.94
-2.84%
0.18%
|
|
Health Technology
|
-1.83%
|
O:
0.78%
H:
0.94%
C:
0.26%
NVO
|
News
|
$108.3
-4.07%
2.17%
|
|
Health Technology
|
-3.14%
|
O:
0.72%
H:
0.0%
C:
0.0%
CCXI
|
$25.08
-3.54%
0.0%
|
|
Health Technology
|
-9.39%
|
O:
-4.88%
H:
1.04%
C:
-1.25%
AZN
|
$65.94
-0.86%
0.21%
|
|
Health Technology
|
-0.86%
|
O:
-0.36%
H:
1.22%
C:
0.38%
AZNCF
|
$127.2501
|
|
Health Technology
|
1.93%
|
O:
-1.55%
H:
4.43%
C:
0.03%
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
0.77%
|
O:
1.86%
H:
1.05%
C:
0.24%
PFE
|
News
|
$50.66
-2.35%
0.4%
|
|
Health Technology
|
-0.16%
|
O:
1.46%
H:
1.45%
C:
0.78%
disease
for
therapy
growth
Irritable Bowel Syndrome Treatment Market to Surpass US$ 3,902.9 Million by 2030 - Coherent Market Insights
Published:
2022-06-24
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
$15.95
|
|
Manufacturing
|
1.38%
|
O:
4.33%
H:
0.0%
C:
-2.44%
ALPMF
|
$15.83
|
|
Health Technology
|
6.07%
|
O:
0.99%
H:
0.0%
C:
-0.5%
ABBV
|
News
|
$152.49
-0.42%
0.0%
|
|
Health Technology
|
2.75%
|
O:
1.57%
H:
0.0%
C:
0.0%
BHC
A
|
$8.83
1.73%
0.11%
|
|
Health Technology
|
21.46%
|
O:
5.78%
H:
13.91%
C:
13.78%
IRWD
|
$11.54
-0.52%
0.0%
|
|
Health Technology
|
4.34%
|
O:
0.27%
H:
2.08%
C:
1.99%
TAK
|
$13.86
-1.42%
0.0%
|
|
Health Technology
|
0.95%
|
O:
0.36%
H:
0.0%
C:
0.0%
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.17%
|
O:
2.38%
H:
0.0%
C:
0.0%
treatment
market
Psoriasis Treatment Market Players Observe Rising Trend of Personalized Medicines, According to TMR Report
Published:
2022-06-24
(Crawled : 12:00)
- prnewswire.com
AZN
|
$65.94
-0.86%
0.21%
|
|
Health Technology
|
3.52%
|
O:
4.41%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$176.94
-2.84%
0.18%
|
|
Health Technology
|
0.07%
|
O:
1.94%
H:
0.0%
C:
0.0%
PFE
|
News
|
$50.66
-2.35%
0.4%
|
|
Health Technology
|
2.8%
|
O:
2.96%
H:
0.0%
C:
0.0%
AZNCF
|
$127.2501
|
|
Health Technology
|
3.95%
|
O:
0.64%
H:
4.18%
C:
1.33%
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.17%
|
O:
2.38%
H:
0.0%
C:
0.0%
LLY
|
News
S
|
$317.62
-2.95%
-0.03%
|
|
Health Technology
|
2.75%
|
O:
3.32%
H:
0.0%
C:
0.0%
treatment
report
psoriasis
market
Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia
Published:
2022-06-24
(Crawled : 12:00)
- globenewswire.com
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.17%
|
O:
2.38%
H:
0.0%
C:
0.0%
scemblix
treatment
for
chmp
novartis
leukemia
positive
Rheumatoid Arthritis Drugs Market Size to Grow by USD 14.90 Billion | 37% of the growth will originate from Europe | Technavio
Published:
2022-06-24
(Crawled : 09:00)
- prnewswire.com
ALPMY
|
$15.95
|
|
Manufacturing
|
1.38%
|
O:
4.33%
H:
0.0%
C:
-2.44%
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
2.92%
|
O:
3.49%
H:
0.0%
C:
0.0%
ALPMF
|
$15.83
|
|
Health Technology
|
6.07%
|
O:
0.99%
H:
0.0%
C:
-0.5%
ABBV
|
News
|
$152.49
-0.42%
0.0%
|
|
Health Technology
|
2.75%
|
O:
1.57%
H:
0.0%
C:
0.0%
GLAXF
|
$21.99
|
|
Health Technology
|
5.59%
|
O:
3.19%
H:
2.28%
C:
-1.81%
AMGN
|
$243.6
-0.51%
0.47%
|
|
Health Technology
|
0.71%
|
O:
0.92%
H:
0.82%
C:
0.56%
GSK
|
$43.35
-0.8%
0.19%
|
|
Health Technology
|
1.93%
|
O:
1.79%
H:
0.95%
C:
0.92%
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.17%
|
O:
2.38%
H:
0.0%
C:
0.0%
GLMD
|
$0.5756
10.69%
0.0%
|
|
Health Technology
|
19.6%
|
O:
1.21%
H:
0.0%
C:
-3.5%
europe
growth
market
Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments
Published:
2022-06-23
(Crawled : 01:00)
- globenewswire.com
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.48%
|
O:
0.3%
H:
0.0%
C:
0.0%
research
disease
novartis
Novartis Tafinlar + Mekinist receives FDA approval for first tumor-agnostic indication for BRAF V600E solid tumors
Published:
2022-06-22
(Crawled : 00:00)
- globenewswire.com
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.48%
|
O:
0.3%
H:
0.0%
C:
0.0%
fda
for
novartis
approval
tafinlar
Global Recombinant Vaccines Market to Surpass US$ 1,809.7 Million by 2030 - Coherent Market Insights
Published:
2022-06-22
(Crawled : 18:00)
- prnewswire.com
JNJ
|
News
|
$176.94
-2.84%
0.18%
|
|
Health Technology
|
4.24%
|
O:
1.36%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
4.41%
|
O:
-0.4%
H:
0.0%
C:
0.0%
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
1.85%
|
O:
-1.57%
H:
0.0%
C:
0.0%
market
Alladapt Announces Completion of Oversubscribed $119 Million Institutional Financing
Published:
2022-06-22
(Crawled : 12:00)
- biospace.com/
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
1.85%
|
O:
-1.57%
H:
0.0%
C:
0.0%
Novartis expands Beacon of Hope through alliances with Historically Black Medical Schools to address systemic health disparities
Published:
2022-06-22
(Crawled : 12:00)
- prnewswire.com
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
4.41%
|
O:
-0.4%
H:
0.0%
C:
0.0%
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
1.85%
|
O:
-1.57%
H:
0.0%
C:
0.0%
beacon
novartis
health
Novartis plans to petition the U.S. Court of Appeals for the Federal Circuit for further review to uphold validity of the Gilenya® (fingolimod) dosing regimen patent
Published:
2022-06-21
(Crawled : 20:00)
- globenewswire.com
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
1.85%
|
O:
-1.57%
H:
0.0%
C:
0.0%
gilenya
patent
for
novartis
review
Liver Cancer Drugs Market size to grow by USD 5.29 billion | Market Research Insights highlight the increasing incidence of liver cancer as Key Driver | Technavio
Published:
2022-06-21
(Crawled : 03:00)
- prnewswire.com
AZN
|
$65.94
-0.86%
0.21%
|
|
Health Technology
|
7.71%
|
O:
2.03%
H:
0.0%
C:
0.0%
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.29%
|
O:
1.41%
H:
0.0%
C:
0.0%
research
liver
cancer
market
Global Meningitis Vaccines Market to Surpass US$ 6,669.3 Million by 2030 - Coherent Market Insights
Published:
2022-06-20
(Crawled : 19:00)
- prnewswire.com
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.29%
|
O:
1.41%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
5.87%
|
O:
1.4%
H:
0.0%
C:
0.0%
market
Global Gene Therapy Market Research Report 2022-2031 Featuring Major Players - Novartis AG; Bluebird bio, Inc.; Spark Therapeutics, Inc; Audentes Therapeutics; Voyager Therapeutics
Published:
2022-06-20
(Crawled : 12:00)
- prnewswire.com
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$108.84
|
|
Health Technology
|
Email alert
Add to watchlist
QURE
|
$18.6
-0.38%
-0.38%
|
|
Health Technology
|
Email alert
Add to watchlist
CLLS
|
News
|
$2.92
-9.03%
0.0%
|
|
Health Technology
|
Email alert
Add to watchlist
SRPT
|
$74.59
-2.24%
-0.13%
|
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$84.01
|
|
Health Technology
|
Email alert
Add to watchlist
AGTC
|
$0.75
2.04%
0.54%
|
|
Health Technology
|
Email alert
Add to watchlist
BLUE
A
|
$4.035
-5.94%
-0.7%
|
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
Email alert
Add to watchlist
research
report
novartis
therapeutics
therapy
market
Global Tacrolimus Market to Surpass US$ 9,380.2 Million by 2030 - Coherent Market Insights
Published:
2022-06-17
(Crawled : 19:00)
- prnewswire.com
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$84.01
|
|
Health Technology
|
Email alert
Add to watchlist
ALPMF
|
$15.83
|
|
Health Technology
|
Email alert
Add to watchlist
MYL
|
$15.86
0%
|
|
Health Technology
|
Email alert
Add to watchlist
TFFP
|
$5.81
-3.65%
4.98%
|
|
Health Technology
|
Email alert
Add to watchlist
ALPMY
|
$15.95
|
|
Manufacturing
|
Email alert
Add to watchlist
tacrolimus
market
Biologic Therapy Market Information: By Product and Geography - Global Forecast till 2025
Published:
2022-06-17
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
$127.2501
|
|
Health Technology
|
10.91%
|
O:
1.89%
H:
0.0%
C:
-0.64%
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.36%
|
O:
0.07%
H:
0.0%
C:
0.0%
GSK
|
$43.35
-0.8%
0.19%
|
|
Health Technology
|
4.48%
|
O:
-0.24%
H:
0.0%
C:
0.0%
NVSEF
|
$84.01
|
|
Health Technology
|
4.91%
|
O:
0.74%
H:
0.52%
C:
-3.23%
GLAXF
|
$21.99
|
|
Health Technology
|
6.81%
|
O:
0.01%
H:
0.17%
C:
0.17%
ABBV
|
News
|
$152.49
-0.42%
0.0%
|
|
Health Technology
|
11.76%
|
O:
1.05%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$108.84
|
|
Health Technology
|
12.02%
|
O:
-1.76%
H:
5.75%
C:
5.5%
JNJ
|
News
|
$176.94
-2.84%
0.18%
|
|
Health Technology
|
5.13%
|
O:
1.35%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.13
-0.89%
0.0%
|
|
Health Technology
|
7.34%
|
O:
1.39%
H:
0.0%
C:
0.0%
AZN
|
$65.94
-0.86%
0.21%
|
|
Health Technology
|
8.35%
|
O:
0.59%
H:
0.0%
C:
0.0%
therapy
market
Global Conjugated Monoclonal Antibodies (mAbs) Market Report 2022: A $12.09 Billion Market by 2026 - Forecast to 2031
Published:
2022-06-17
(Crawled : 13:20)
- prnewswire.com
ABBV
|
News
|
$152.49
-0.42%
0.0%
|
|
Health Technology
|
11.76%
|
O:
1.05%
H:
0.0%
C:
0.0%
NVS
|
$84.17
-1.3%
0.17%
|
|
Health Technology
|
3.36%
|
O:
0.07%
H:
0.0%
C:
0.0%
NVSEF
|
$84.01
|
|
Health Technology
|
4.91%
|
O:
0.74%
H:
0.52%
C:
-3.23%
report
market
← Previous
1
2
3
4
5
6
7
8
9
…
24
25
Next →
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
ACN
|
News
|
$283.8
-3.01%
0.07%
|
|
Technology Services
BTG
|
News
|
$3.56
-2.73%
0.84%
|
|
Non-Energy Minerals
DELL
|
News
|
$48.94
-2.59%
0.0%
|
|
Electronic Technology
DKILF
|
News
|
$166.37
|
|
Producer Manufacturing
DKILY
|
News
|
$16.05
|
|
Manufacturing
GBERF
|
News
|
$546.0
|
|
Producer Manufacturing
GBERY
|
News
|
$49.49
|
|
Manufacturing
GLPI
|
News
0 d
|
$46.68
-0.09%
0.0%
|
|
Finance
INCY
|
News
|
$75.64
-2.22%
0.93%
|
|
Health Technology
JCI
|
News
|
$48.44
-0.43%
0.0%
|
|
Producer Manufacturing
JTEKF
|
News
|
$
0%
|
|
Producer Manufacturing
JTEKY
|
News
|
$24.29
|
|
Manufacturing
LEA
|
News
|
$134.75
0.57%
0.0%
|
|
Producer Manufacturing
LLY
|
News
4
|
$317.62
-2.95%
-0.03%
|
|
Health Technology
NDAQ
|
News
4
|
$154.64
-2.08%
-0.23%
|
|
Finance
PCRFF
|
News
|
$8.15
|
|
n/a
PCRFY
|
News
|
$8.22
|
|
n/a
PPRUF
|
News
|
$534.0
|
|
Consumer Non-Durables
PPRUY
|
News
|
$52.24
|
|
Manufacturing
TMO
|
News
|
$535.77
-1.45%
-0.09%
|
|
Health Technology